---
figid: PMC8914548__gr11
figtitle: TFPI2 suppresses the interaction of TGFB2 pathway regulators to promote
  endothelial–mesenchymal transition in diabetic nephropathy
organisms:
- Adenoviridae
- Adeno-associated virus
- adeno-associated virus 2
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Armoracia rusticana
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC8914548
filename: gr11.jpg
figlink: /pmc/articles/PMC8914548/figure/fig11/
number: F11
caption: 'The potential mechanism underlying TFPI2-mediated EndMT and fibrosis in
  DN: involvement of TGF-β/Smad signaling. TFPI2, as a downstream target gene of TGF-β/Smad
  signal, is induced upon TGF-β2 stimulation. In the presence of TGF-β2, TFPI2 interacts
  with SMURF2 and inhibits SMURF2/SMAD7 interaction, and thus suppressing TGFBRs degradation,
  leading to Smads signaling activation. Subsequently, TFPI2-induced activation of
  TGF-β/Smad signaling promotes EndMT and renal fibrosis. EndMT, endothelial–mesenchymal
  transition; SMURF2, SMAD ubiquitination regulatory factor-2; TFP12, tissue factor
  pathway inhibitor 2; TGFBR, TGF-β receptor.'
papertitle: TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote
  endothelial–mesenchymal transition in diabetic nephropathy.
reftext: Guoying Guan, et al. J Biol Chem. 2022 Mar;298(3):101725.
year: '2022'
doi: 10.1016/j.jbc.2022.101725
journal_title: The Journal of Biological Chemistry
journal_nlm_ta: J Biol Chem
publisher_name: American Society for Biochemistry and Molecular Biology
keywords: diabetic nephropathy | TFPI2 | endothelial–mesenchymal transition | SMURF2
  | SMAD7 | TGF-β2/Smad signaling | AAV, adeno-associated virus | BUN, blood urea
  nitrogen | DN, diabetic nephropathy | ECM, extracellular matrix | EMT, epithelial–mesenchymal
  transition | EndMT, endothelial–mesenchymal transition | GEO, Gene Expression Omnibus
  | hRGEC, human renal glomerular endothelial cell | NGAL, neutrophil gelatinase-associated
  lipocalin | SMURF2, SMAD ubiquitination regulatory factor-2 | STZ, streptozotocin
  | TGF-β, transforming growth factor beta | TFP12, tissue factor pathway inhibitor
  2
automl_pathway: 0.9438072
figid_alias: PMC8914548__F11
figtype: Figure
redirect_from: /figures/PMC8914548__F11
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8914548__gr11.html
  '@type': Dataset
  description: 'The potential mechanism underlying TFPI2-mediated EndMT and fibrosis
    in DN: involvement of TGF-β/Smad signaling. TFPI2, as a downstream target gene
    of TGF-β/Smad signal, is induced upon TGF-β2 stimulation. In the presence of TGF-β2,
    TFPI2 interacts with SMURF2 and inhibits SMURF2/SMAD7 interaction, and thus suppressing
    TGFBRs degradation, leading to Smads signaling activation. Subsequently, TFPI2-induced
    activation of TGF-β/Smad signaling promotes EndMT and renal fibrosis. EndMT, endothelial–mesenchymal
    transition; SMURF2, SMAD ubiquitination regulatory factor-2; TFP12, tissue factor
    pathway inhibitor 2; TGFBR, TGF-β receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Smurf2
  - Smad7
  - Tgfbr1
  - Tgfbr2
  - Tgfb2
  - Smad4
  - Smad3
  - Smad2
  - SMURF2
  - SMAD7
  - TGFBR1
  - TGFBR2
  - TGFB2
  - SMAD4
  - SMAD3
  - SMAD2
  - smurf2
  - smad7
  - tgfbr1a
  - tgfbr2b
  - tgfb2
  - smad4a
  - smad4b
  - smad3a
  - smad2
---
